We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
ImmunoGen Inc | NASDAQ:IMGN | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 31.235 | 32.80 | 29.67 | 0 | 01:00:00 |
|
Massachusetts
|
| |
04-2726691
|
|
|
(State or other jurisdiction of
incorporation or organization) |
| |
(I.R.S. Employer
Identification No.) |
|
| Large accelerated filer ☐ | | | Accelerated filer ☒ | | | Non-accelerated filer ☐ | | |
Smaller reporting company ☒
Emerging growth company ☐ |
|
| | |||||||||||||||||||
Title of Each Class of Securities
to be Registered |
| | |
Amount to
Be Registered(1)(2) |
| | |
Proposed Maximum
Offering Price Per Securities(1)(2) |
| | |
Proposed Maximum
Aggregate Offering Price(1)(2) |
| | |
Amount of
Registration Fee(3) |
| |||
Common Stock, $.01 par value
|
| | | | | | | | | | | | | | | | $ | 0 | | |
Preferred Stock, $.01 par value
|
| | | | | | | | | | | | | | | | $ | 0 | | |
Debt Securities
|
| | | | | | | | | | | | | | | | $ | 0 | | |
Warrants
|
| | | | | | | | | | | | | | | | $ | 0 | | |
Units
|
| | | | | | | | | | | | | | | | $ | 0 | | |
Total
|
| | | | | | | | | | | | | | | | $ | 0 | | |
| | |
Page
|
| |||
| | | | 1 | | | |
| | | | 2 | | | |
| | | | 5 | | | |
| | | | 5 | | | |
| | | | 6 | | | |
| | | | 6 | | | |
| | | | 6 | | | |
| | | | 7 | | | |
| | | | 13 | | | |
| | | | 14 | | | |
| | | | 14 | | | |
| | | | 14 | | | |
| | | | 16 | | | |
| | | | 16 | | | |
| | | | 16 | | | |
| | | | 16 | | |
|
SEC Registration Fee
|
| | | | * | | |
|
Printing and Engraving Fees
|
| | | | ** | | |
|
Legal Fees and Expenses
|
| | | | ** | | |
|
Accounting Fees and Expenses
|
| | | | ** | | |
|
Miscellaneous Fees and Expenses
|
| | | | ** | | |
| Total | | | | | ** | | |
Number
|
| |
Description
|
|
5.1 | | | Opinion of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. with respect to the legality of the securities being registered. | |
23.1 | | | Consent of Ernst & Young LLP. | |
23.2 | | | Consent of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. (included in the opinion filed as Exhibit 5.1). | |
24.1 | | | Power of Attorney (included on signature page). | |
25.1** | | | The Statement of Eligibility on Form T-1 under the Trust Indenture Act of 1939, as amended, of the Trustee under the Senior Indenture. | |
25.2** | | | The Statement of Eligibility on Form T-1 under the Trust Indenture Act of 1939, as amended, of the Trustee under the Subordinated Indenture. | |
Signature
|
| |
Title
|
| |
Date
|
|
/s/ Mark J. Enyedy
Mark J. Enyedy
|
| |
President, Chief Executive Officer and Director
(principal executive officer) |
| |
December 18, 2020
|
|
/s/ Susan M. Altschuller
Susan M. Altschuller
|
| | Senior Vice President and Chief Financial Officer (principal financial officer) | | |
December 18, 2020
|
|
/s/ David G. Foster
David G. Foster
|
| | Vice President, Finance (principal accounting officer) | | |
December 18, 2020
|
|
/s/ Stephen C. McCluski
Stephen C. McCluski
|
| | Chairman of the Board | | |
December 18, 2020
|
|
/s/ Stuart A. Arbuckle
Stuart A. Arbuckle
|
| | Director | | |
December 18, 2020
|
|
/s/ Mark Goldberg
Mark Goldberg
|
| | Director | | |
December 18, 2020
|
|
Signature
|
| |
Title
|
| |
Date
|
|
/s/ Dean J. Mitchell
Dean J. Mitchell
|
| | Director | | |
December 18, 2020
|
|
/s/ Kristine Peterson
Kristine Peterson
|
| | Director | | |
December 18, 2020
|
|
/s/ Richard J. Wallace
Richard J. Wallace
|
| | Director | | |
December 18, 2020
|
|
1 Year ImmunoGen Chart |
1 Month ImmunoGen Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions